A citation-based method for searching scientific literature

Gregory Aubert, Ola J Martin, Julie L Horton, Ling Lai, Rick B Vega, Teresa C Leone, Timothy Koves, Stephen J Gardell, Marcus Krüger, Charles L Hoppel, E Douglas Lewandowski, Peter A Crawford, Deborah M Muoio, Daniel P Kelly. Circulation 2016
Times Cited: 283







List of co-cited articles
1187 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mitophagy Is Essential for Maintaining Cardiac Function During High Fat Diet-Induced Diabetic Cardiomyopathy.
Mingming Tong, Toshiro Saito, Peiyong Zhai, Shin-Ichi Oka, Wataru Mizushima, Michinari Nakamura, Shohei Ikeda, Akihiro Shirakabe, Junichi Sadoshima. Circ Res 2019
92
6

Metabolism in cardiomyopathy: every substrate matters.
Julia Ritterhoff, Rong Tian. Cardiovasc Res 2017
85
7

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure.
Nikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, Mourad Ferdaoussi, Shingo Takahara, Ahmed M Darwesh, Jody L Levasseur, James Won Suk Jahng, Dyonne Vos, Nirmal Parajuli,[...]. Circ Heart Fail 2020
37
16

Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.
Pavel Zhabyeyev, Manoj Gandhi, Jun Mori, Ratnadeep Basu, Zamaneh Kassiri, Alexander Clanachan, Gary D Lopaschuk, Gavin Y Oudit. Cardiovasc Res 2013
79
7

Ketones can become the major fuel source for the heart but do not increase cardiac efficiency.
Kim L Ho, Qutuba G Karwi, Cory Wagg, Liyan Zhang, Katherina Vo, Tariq Altamimi, Golam M Uddin, John R Ussher, Gary D Lopaschuk. Cardiovasc Res 2021
11
54

Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure.
Wynn G Hunter, Jacob P Kelly, Robert W McGarrah, Michel G Khouri, Damian Craig, Carol Haynes, Olga Ilkayeva, Robert D Stevens, James R Bain, Michael J Muehlbauer,[...]. J Am Heart Assoc 2016
83
7


Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning.
Nikolaos A Diakos, Sutip Navankasattusas, E Dale Abel, Jared Rutter, Lauren McCreath, Peter Ferrin, Stephen H McKellar, Dylan V Miller, Song Y Park, Russell S Richardson,[...]. JACC Basic Transl Sci 2016
53
11

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.
So Ra Kim, Sang-Guk Lee, Soo Hyun Kim, Jin Hee Kim, Eunhye Choi, Wonhee Cho, John Hoon Rim, Inhwa Hwang, Chan Joo Lee, Minyoung Lee,[...]. Nat Commun 2020
52
11

Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
Salva R Yurista, Timothy R Matsuura, Herman H W Silljé, Kirsten T Nijholt, Kendra S McDaid, Swapnil V Shewale, Teresa C Leone, John C Newman, Eric Verdin, Dirk J van Veldhuisen,[...]. Circ Heart Fail 2021
14
42

Regulation of fatty acid oxidation in the mammalian heart in health and disease.
G D Lopaschuk, D D Belke, J Gamble, T Itoi, B O Schönekess. Biochim Biophys Acta 1994
444
5

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes.
H J Lambers Heerspink, D de Zeeuw, L Wie, B Leslie, J List. Diabetes Obes Metab 2013
419
5

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.
Giuseppe Daniele, Juan Xiong, Carolina Solis-Herrera, Aurora Merovci, Roy Eldor, Devjit Tripathy, Ralph A DeFronzo, Luke Norton, Muhammad Abdul-Ghani. Diabetes Care 2016
87
5


Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.
Edward T Chouchani, Victoria R Pell, Edoardo Gaude, Dunja Aksentijević, Stephanie Y Sundier, Ellen L Robb, Angela Logan, Sergiy M Nadtochiy, Emily N J Ord, Anthony C Smith,[...]. Nature 2014
5

Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease.
Ben A Kappel, Michael Lehrke, Katharina Schütt, Anna Artati, Jerzy Adamski, Corinna Lebherz, Nikolaus Marx. Circulation 2017
63
7

Lipid metabolism and toxicity in the heart.
Ira J Goldberg, Chad M Trent, P Christian Schulze. Cell Metab 2012
267
5


Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus.
S Sha, D Polidori, T Heise, J Natarajan, K Farrell, S-S Wang, D Sica, P Rothenberg, L Plum-Mörschel. Diabetes Obes Metab 2014
139
5

SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.
Liang Xu, Naoto Nagata, Mayumi Nagashimada, Fen Zhuge, Yinhua Ni, Guanliang Chen, Eric Mayoux, Shuichi Kaneko, Tsuguhito Ota. EBioMedicine 2017
134
5

Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox.
Sowndramalingam Sankaralingam, Osama Abo Alrob, Liyan Zhang, Jagdip S Jaswal, Cory S Wagg, Arata Fukushima, Raj S Padwal, David E Johnstone, Arya M Sharma, Gary D Lopaschuk. Diabetes 2015
39
12


Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.
Danilo Neglia, Alberto De Caterina, Paolo Marraccini, Andrea Natali, Marco Ciardetti, Cecilia Vecoli, Amalia Gastaldelli, Demetrio Ciociaro, Paola Pellegrini, Roberto Testa,[...]. Am J Physiol Heart Circ Physiol 2007
112
5

Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
Wei Wang, Fuyang Zhang, Yunlong Xia, Shihao Zhao, Wenjun Yan, Helin Wang, Yan Lee, Congye Li, Ling Zhang, Kun Lian,[...]. Am J Physiol Heart Circ Physiol 2016
55
9

Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.
Mark Y Jeong, Ying H Lin, Sara A Wennersten, Kimberly M Demos-Davies, Maria A Cavasin, Jennifer H Mahaffey, Valmen Monzani, Chandrasekhar Saripalli, Paolo Mascagni, T Brett Reece,[...]. Sci Transl Med 2018
61
8

Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target.
Alessandra Di Franco, Giulia Cantini, Alessia Tani, Raffaele Coppini, Sandra Zecchi-Orlandini, Laura Raimondi, Michaela Luconi, Edoardo Mannucci. Int J Cardiol 2017
69
7

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
5


Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A Abdul-Ghani,[...]. J Clin Invest 2014
467
5

Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.
Anne Van Steenbergen, Magali Balteau, Audrey Ginion, Laura Ferté, Sylvain Battault, Christophe de Meester de Ravenstein, Jean-Luc Balligand, Evangelos-Panagiotis Daskalopoulos, Patrick Gilon, Florin Despa,[...]. Sci Rep 2017
32
15

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.
David Fitchett, Bernard Zinman, Christoph Wanner, John M Lachin, Stefan Hantel, Afshin Salsali, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Silvio E Inzucchi. Eur Heart J 2016
554
5

Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms.
Sarah J Mancini, Daria Boyd, Omar J Katwan, Anastasiya Strembitska, Tarek A Almabrouk, Simon Kennedy, Timothy M Palmer, Ian P Salt. Sci Rep 2018
76
6

The Role of Autophagy in the Heart.
Sebastiano Sciarretta, Yasuhiro Maejima, Daniela Zablocki, Junichi Sadoshima. Annu Rev Physiol 2018
138
5

The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Michael Joubert, Benoît Jagu, David Montaigne, Xavier Marechal, Angela Tesse, Audrey Ayer, Lucile Dollet, Cédric Le May, Gilles Toumaniantz, Alain Manrique,[...]. Diabetes 2017
67
7

Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis.
Karen M Hallow, Gabriel Helmlinger, Peter J Greasley, John J V McMurray, David W Boulton. Diabetes Obes Metab 2018
160
5

Cardiac effects of SGLT2 inhibitors: the sodium hypothesis.
Edoardo Bertero, Leticia Prates Roma, Pietro Ameri, Christoph Maack. Cardiovasc Res 2018
65
7

SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms.
Soravis Osataphan, Chiara Macchi, Garima Singhal, Jeremy Chimene-Weiss, Vicencia Sales, Chisayo Kozuka, Jonathan M Dreyfuss, Hui Pan, Yanin Tangcharoenpaisan, Jordan Morningstar,[...]. JCI Insight 2019
53
9

Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.
C David Mazer, Gregory M T Hare, Philip W Connelly, Richard E Gilbert, Nadine Shehata, Adrian Quan, Hwee Teoh, Lawrence A Leiter, Bernard Zinman, Peter Jüni,[...]. Circulation 2020
78
6

Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
S Neubauer, M Horn, M Cramer, K Harre, J B Newell, W Peters, T Pabst, G Ertl, D Hahn, J S Ingwall,[...]. Circulation 1997
489
5

Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Guanghong Jia, Adam Whaley-Connell, James R Sowers. Diabetologia 2018
186
5


Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry.
Toshiyuki Fukao, Gary D Lopaschuk, Grant A Mitchell. Prostaglandins Leukot Essent Fatty Acids 2004
195
5

Novel ketone diet enhances physical and cognitive performance.
Andrew J Murray, Nicholas S Knight, Mark A Cole, Lowri E Cochlin, Emma Carter, Kirill Tchabanenko, Tica Pichulik, Melanie K Gulston, Helen J Atherton, Marie A Schroeder,[...]. FASEB J 2016
83
6

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat Med 2015
380
5

Metabolic Regulation of Gene Expression by Histone Lysine β-Hydroxybutyrylation.
Zhongyu Xie, Di Zhang, Dongjun Chung, Zhanyun Tang, He Huang, Lunzhi Dai, Shankang Qi, Jingya Li, Gozde Colak, Yue Chen,[...]. Mol Cell 2016
174
5

Hormone-fuel interrelationships during fasting.
G F Cahill, M G Herrera, A P Morgan, J S Soeldner, J Steinke, P L Levy, G A Reichard, D M Kipnis. J Clin Invest 1966
5

Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts.
Moshi Song, Katsuyoshi Mihara, Yun Chen, Luca Scorrano, Gerald W Dorn. Cell Metab 2015
255
5

Molecular mechanisms of diabetic cardiomyopathy.
Heiko Bugger, E Dale Abel. Diabetologia 2014
419
5

Mitochondrial Reactive Oxygen Species in Lipotoxic Hearts Induce Post-Translational Modifications of AKAP121, DRP1, and OPA1 That Promote Mitochondrial Fission.
Kensuke Tsushima, Heiko Bugger, Adam R Wende, Jamie Soto, Gregory A Jenson, Austin R Tor, Rose McGlauflin, Helena C Kenny, Yuan Zhang, Rhonda Souvenir,[...]. Circ Res 2018
96
5

Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
Georgios Karamanlidis, Chi Fung Lee, Lorena Garcia-Menendez, Stephen C Kolwicz, Wichit Suthammarak, Guohua Gong, Margaret M Sedensky, Philip G Morgan, Wang Wang, Rong Tian. Cell Metab 2013
232
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.